 |
PDBsum entry 2mcy
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
2mcy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Cr1 sushi domains 2 and 3
|
|
Structure:
|
 |
Complement receptor type 1. Chain: a. Fragment: sushi domains 2 and 3(unp residues 102-233). Synonym: c3b/c4b receptor. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: cr1, c3br. Expressed in: komagataella pastoris. Expression_system_taxid: 4922.
|
|
NMR struc:
|
 |
20 models
|
 |
|
Authors:
|
 |
H.J.Park,M.J.Guariento,M.Maciejewski,R.Hauart,W.Tham,A.F.Cowman, C.Q.Schmidt,H.Martens,K.M.Liszewski,D.Hourcade,P.N.Barlow, J.P.Atkinson
|
|
Key ref:
|
 |
H.J.Park
et al.
(2014).
Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.
J Biol Chem,
289,
450-463.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
27-Aug-13
|
Release date:
|
13-Nov-13
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P17927
(CR1_HUMAN) -
Complement receptor type 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
2039 a.a.
132 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
289:450-463
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.
|
|
H.J.Park,
M.Guariento,
M.Maciejewski,
R.Hauhart,
W.H.Tham,
A.F.Cowman,
C.Q.Schmidt,
H.D.Mertens,
M.K.Liszewski,
D.E.Hourcade,
P.N.Barlow,
J.P.Atkinson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
To survive and replicate within the human host, malaria parasites must invade
erythrocytes. Invasion can be mediated by the P. falciparum reticulocyte-binding
homologue protein 4 (PfRh4) on the merozoite surface interacting with complement
receptor type 1 (CR1, CD35) on the erythrocyte membrane. The PfRh4 attachment
site lies within the three N-terminal complement control protein modules (CCPs
1-3) of CR1, which intriguingly also accommodate binding and regulatory sites
for the key complement activation-specific proteolytic products, C3b and C4b.
One of these regulatory activities is decay-accelerating activity. Although
PfRh4 does not impact C3b/C4b binding, it does inhibit this convertase
disassociating capability. Here, we have employed ELISA, co-immunoprecipitation,
and surface plasmon resonance to demonstrate that CCP 1 contains all the
critical residues for PfRh4 interaction. We fine mapped by homologous
substitution mutagenesis the PfRh4-binding site on CCP 1 and visualized it with
a solution structure of CCPs 1-3 derived by NMR and small angle x-ray
scattering. We cross-validated these results by creating an artificial
PfRh4-binding site through substitution of putative PfRh4-interacting residues
from CCP 1 into their homologous positions within CCP 8; strikingly, this
engineered binding site had an ∼30-fold higher affinity for PfRh4 than the
native one in CCP 1. These experiments define a candidate site on CR1 by which
P. falciparum merozoites gain access to human erythrocytes in a non-sialic
acid-dependent pathway of merozoite invasion.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |